It is very uncertain whether intermittent short‐course anti‐TB regimens changes cure compared with daily anti‐TB regimens (very low certainty).
It is very uncertain whether intermittent short‐course anti‐TB regimens changes death from any cause compared with daily anti‐TB regimens (very low certainty).
It is very uncertain whether intermittent short‐course anti‐TB regimens changes relapse compared with daily anti‐TB regimens (very low certainty).
It is very uncertain whether intermittent short‐course anti‐TB regimens changes adherence to treatment compared with daily anti‐TB regimens (very low certainty).
It is very uncertain whether intermittent short‐course anti‐TB regimens changes treatment‐limiting adverse events compared with daily anti‐TB regimens (very low certainty).
The intervention probably leads to lower clinical malaria (moderate certainty).
The intervention showed no clear difference in hospital admission for any reason (moderate certainty).
The review found no eligible studies for this question.
The intervention showed no clear difference in anaemia (moderate certainty).
The intervention probably leads to lower clinical malaria (moderate certainty).
The intervention showed no clear difference in severe malaria (moderate certainty).
The intervention showed no clear difference in all‐cause mortality (low certainty).
The intervention showed no clear difference in hospital admission for any reason (low certainty).
The intervention leads to lower clinical malaria (high certainty).
The intervention showed no clear difference in severe malaria (low certainty).
The review found no eligible studies for this question.
The intervention showed no clear difference in all‐cause mortality (moderate certainty).
The intervention showed no clear difference in hospital admission for any reason (moderate certainty).